sepofarsen
PQ-110-003
Phase 3 small_molecule active
Quick answer
sepofarsen for Leber Congenital Amaurosis 10 is a Phase 3 program (small_molecule) at ProQR Therapeutics N.V. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ProQR Therapeutics N.V.
- Indication
- Leber Congenital Amaurosis 10
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active